TIZIMLI SKLERODERMIYA
Article Sidebar
Main Article Content
Аннотация:
Mazkur maqolada tizimli skleroderma kasalligi etiologiyasi, epidemiologiyasi va kasallikning differensial diagnostikasi hamda, prognozi haqida sharhlar keltirilgan. Tizimli skleroz yoki skleroderma - noma'lum va murakkab patogenezi bo'lgan kam uchraydigan biriktiruvchi to'qima kasalligi. Sklerodermani ikkita asosiy shaklga bo'lish mumkin - mahalliylashtirilgan skleroderma (shu jumladan morfea, chiziqli skleroderma va skleroderma en coup de sabre) va tizimli skleroz. Tizimli sklerozni klinik va serologik mezonlarga ko‘ra cheklangan tizimli skleroz (ilgari CREST sindromi deb atalgan, kalsinoz, Reyno fenomeni, qizilo‘ngach dismotiliyasi, sklerodaktiliya va telangiektaziya bilan tavsiflanadi) yoki diffuz tizimli skleroz sifatida tasniflash mumkin. Mahalliylashtirilgan skleroderma birinchi navbatda teri va teri osti to'qimalariga ta'sir qiladi, tizimli skleroz esa tizimli ko'rinishlar va ichki organlarning ishtiroki bilan bog'liq bo'lib, o'limning oshishiga olib keladi. Sklerodermaning namoyon bo'lishi boshqa revmatologik yoki immunologik kasalliklar bilan juda mos kelishi mumkin.
Article Details
Как цитировать:
Библиографические ссылки:
RODNAN GP, BENEDEK TG. An historical account of the study of progressive systemic sclerosis (diffuse scleroderma). Ann Intern Med. 1962 Aug;57:305-19.
WINTERBAUER RH. MULTIPLE TELANGIECTASIA, RAYNAUD'S PHENOMENON, SCLERODACTYLY, AND SUBCUTANIOUS CALCINOSIS: A SYNDROME MIMICKING HEREDITARY HEMORRHAGIC TELANGIECTASIA. Bull Johns Hopkins Hosp. 1964 Jun;114:361-83.
Arkachaisri T, Fertig N, Pino S, Medsger TA. Serum autoantibodies and their clinical associations in patients with childhood- and adult-onset linear scleroderma. A single-center study. J Rheumatol. 2008 Dec;35(12):2439-44.
LeRoy EC, Medsger TA. Criteria for the classification of early systemic sclerosis. J Rheumatol. 2001 Jul;28(7):1573-6.
Politikou O, Giesen T, Reissner L, Calcagni M. Hand and wrist joint procedures in patients with scleroderma: a systematic review. J Hand Surg Eur Vol. 2019 May;44(4):402-407.
Arnett FC, Cho M, Chatterjee S, Aguilar MB, Reveille JD, Mayes MD. Familial occurrence frequencies and relative risks for systemic sclerosis (scleroderma) in three United States cohorts. Arthritis Rheum. 2001 Jun;44(6):1359-62.
Assassi S, Arnett FC, Reveille JD, Gourh P, Mayes MD. Clinical, immunologic, and genetic features of familial systemic sclerosis. Arthritis Rheum. 2007 Jun;56(6):2031-7.
González-Serna D, Shi C, Kerick M, Hankinson J, Ding J, McGovern A, Tutino M, Villanueva-Martin G, Ortego-Centeno N, Callejas JL, Martin J, Orozco G. Identification of Mechanisms by Which Genetic Susceptibility Loci Influence Systemic Sclerosis Risk Using Functional Genomics in Primary T Cells and Monocytes. Arthritis Rheumatol. 2023 Jun;75(6):1007-1020
McCormic ZD, Khuder SS, Aryal BK, Ames AL, Khuder SA. Occupational silica exposure as a risk factor for scleroderma: a meta-analysis. Int Arch Occup Environ Health. 2010 Oct;83(7):763-9.
Hertzman PA, Blevins WL, Mayer J, Greenfield B, Ting M, Gleich GJ. Association of the eosinophilia-myalgia syndrome with the ingestion of tryptophan. N Engl J Med. 1990 Mar 29;322(13):869-73.
Ingegnoli F, Ughi N, Mihai C. Update on the epidemiology, risk factors, and disease outcomes of systemic sclerosis. Best Pract Res Clin Rheumatol. 2018 Apr;32(2):223-240.
Mayes MD, Lacey JV, Beebe-Dimmer J, Gillespie BW, Cooper B, Laing TJ, Schottenfeld D. Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum. 2003 Aug;48(8):2246-55.
Najmiddinov A., Ibragimova N., Muxitdinova G. SILIKOZ PATOGENEZIDA KREMNIY DIOKSIDI VA YALLIGʻLANISH MEDIATORLARINING OʻRNI //Евразийский журнал медицинских и естественных наук. – 2023. – Т. 3. – №. 12. – С. 63-77.
Tamaki T, Mori S, Takehara K. Epidemiological study of patients with systemic sclerosis in Tokyo. Arch Dermatol Res. 1991;283(6):366-71.
Kuo CF, See LC, Yu KH, Chou IJ, Tseng WY, Chang HC, Shen YM, Luo SF. Epidemiology and mortality of systemic sclerosis: a nationwide population study in Taiwan. Scand J Rheumatol. 2011;40(5):373-8.
Шодикулова Г. З., Мухитдинова Г. З., Атоев Т. Т. ОЦЕНКА СОСТОЯНИЯ ЦЕНТРАЛЬНОЙ ГЕМОДИНАМИКИ У БОЛЬНЫХ С ХРОНИЧЕСКИМИ БОЛЕЗНЯМИ ПОЧЕК В САМАРКАНДСКОМ РЕГИОНЕ //Достижения науки и образования. – 2021. – №. 8 (80). – С. 59-63.
Zikriyayevna S. G., Zoxirovna M. G., To’raqulovna Q. S. PREVENTION OF CHRONIC KIDNEY DISEASE AND CHRONIC HEART FAILURE //Spectrum Journal of Innovation, Reforms and Development. – 2022. – Т. 4. – С. 408-414.
Laing TJ, Gillespie BW, Toth MB, Mayes MD, Gallavan RH, Burns CJ, Johanns JR, Cooper BC, Keroack BJ, Wasko MC, Lacey JV, Schottenfeld D. Racial differences in scleroderma among women in Michigan. Arthritis Rheum. 1997 Apr;40(4):734-42.
Argentino G, Barbieri A, Beri R, Bason C, Ruzzenente A, Olivieri O, Tinazzi E, Puccetti A, Vitali C, Del Papa N, Friso S, Lunardi C. Profibrotic Effects of Endothelin-1 on Fibroblasts Are Mediated by Aldosterone in Vitro: Relevance to the Pathogenesis and Therapy of Systemic Sclerosis and Pulmonary Arterial Hypertension. Biomedicines. 2022 Oct 31;10(11)
Zikiryayevna S. G. et al. Kidney Damage in Patients with Chronic Cardiac Insufficiency and Obesity //Texas Journal of Medical Science. – 2022. – Т. 13. – С. 72-78.
Liu X, Dai K, Zhang X, Huang G, Lynn H, Rabata A, Liang J, Noble PW, Jiang D. Multiple Fibroblast Subtypes Contribute to Matrix Deposition in Pulmonary Fibrosis. Am J Respir Cell Mol Biol. 2023 Jul;69(1):45-56.
Bozorova Chekhroza Sodik kizi , M. G. Z. . , K. T. A. U. . ,. (2024). Clinical and Immunological Features of the Diffuse Form of Systemic Scleroderma. American Journal of Pediatric Medicine and Health Sciences (2993-2149), 2(3), 433–436. Retrieved from https://grnjournal.us/index.php/AJPMHS/article/view/4018
Zohirovna, M. G. (2024). Changes in the Structural and Functional State of Myocardium in Patients with Chronic Kidney Disease at Different Stages of Development. International Journal of Alternative and Contemporary Therapy, 2(5), 73–76. Retrieved from https://medicaljournals.eu/index.php/IJACT/article/view/321
Пардаевна, С. М. (2024). Определить Значение Факторов Риска Инфаркт Миокарда. Journal of Science in Medicine and Life, 2(6), 72–74. Retrieved from https://journals.proindex.uz/index.php/JSML/article/view/1223
Pardaevna S. M. COMORBIDITY: CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND CARDIOVASCULAR DISEASES //JOURNAL OF HEALTHCARE AND LIFE-SCIENCE RESEARCH. – 2024. – Т. 3. – №. 6. – С. 252-256.
Negmatulllaevna M. N., Pardaevna S. M. CLINICAL CHARACTERISTICS OF NONSPECIFIC INTERSTITIAL PNEUMONIA //World Bulletin of Public Health. – 2024. – Т. 32. – С. 142-143.
Pardaevna S. M., Akmalov A. N. Dynamical Assessment of Bronchial Asthma Characteristics and Electrocardiographic Changes //Miasto Przyszłości. – 2024. – Т. 46. – С. 153-156.
Махматмурадова Н. Н., Сафарова М. П. НЕОТЛОЖНЫЕ МЕРОПРИЯТИЯ ПРИ КАРДИОГЕННОМ ШОКЕ //ЗДОРОВЬЕ, ДЕМОГРАФИЯ, ЭКОЛОГИЯ ФИННО-УГОРСКИХ НАРОДОВ HEALTH, DEMOGRAPHY, ECOLOGY. – 2018. – С. 60.